Co-pay Assistance Program
At Novartis, we are committed to supporting you with your treatment.
That is why we developed a co-pay assistance program—so you can access the medicine you need.
ELIGIBLE PATIENTS PAY A $10 CO-PAY FOR THEIR TAFINLAR + MEKINIST PRESCRIPTIONS*
You may be eligible for immediate co-pay savings on your next prescription of TAFINLAR or MEKINIST. If you are commercially insured, you may complete a 5-minute survey to activate this co-pay offer. If eligible, you may:
*Limitations apply. See Program Terms and Conditions here. This offer is not valid under Medicare, Medicaid, or any other federal or state program, or for cash-paying patients. Novartis reserves the right to rescind, revoke, or amend this program without notice.
Terms and Conditions:
This offer is valid only for those with commercial insurance. Offer not valid under Medicare, Medicaid, or any other federal or state program. Not valid for cash-paying patients, where product is not covered by patient's commercial insurance, or where plan reimburses you for entire cost of your prescription drug. Offer is not valid where prohibited by law. Valid only in the United States and Puerto Rico. This program is not health insurance. Offer may not be combined with any other rebate, coupon, or offer. The card is the property of Novartis Pharmaceuticals Corporation and must be returned upon request. Novartis reserves the right to rescind, revoke, or amend the program without notice. Patient certifies responsibility for complying with applicable limitations, if any, of any commercial insurance and reporting receipt of program rewards, if necessary, to any commercial insurer. This offer expires on December 31, 2016.
Patient Assistance Now Oncology
Novartis Oncology is committed to helping patients receive the medicines they need. Patient Assistance Now Oncology (PANO) offers quick and easy access to information about our wide range of resources.
You can get information about our PANO support programs in 2 ways: